Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-036415
Filing Date
2014-05-22
Accepted
2014-05-22 20:15:19
Documents
1
Period of Report
2014-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4030
  Complete submission text file 0001209191-14-036415.txt   5287
Mailing Address
Business Address
GLENN SCOTT L (Reporting) CIK: 0001284095 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 14865258

Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations